Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 May 26:15:190.
doi: 10.1186/1745-6215-15-190.

Staged transthoracic approach to persistent atrial fibrillation (TOP-AF): study protocol for a randomized trial

Claudio Pragliola  1 , Pasquale Mastroroberto, Mario Gaudino, Massimo Chello, Elvio Covino
Affiliations
Randomized Controlled Trial

Staged transthoracic approach to persistent atrial fibrillation (TOP-AF): study protocol for a randomized trial

Claudio Pragliola et al. Trials. .

Abstract

Background: Persistent atrial fibrillation frequently shows multiple different electrophysiological mechanisms of induction. This heterogeneity causes a low success rate of single procedures of ablation and a high incidence of recurrence. Surgical ablation through bilateral thoracotomy demonstrates better results after a single procedure. Prospective observational studies in inhomogeneous populations without control groups report a remarkable 90% of success with hybrid or staged procedures of surgical ablation coupled with catheter ablation. In this trial, we will examine the hypothesis that a staged approach involving initial minimally invasive surgical ablation of persistent atrial fibrillation, followed by a second percutaneous procedure in case of recurrence, has a higher success rate than repeated percutaneous procedures.

Methods/design: This is a controlled (2:1) randomized trial comparing use of a percutaneous catheter with minimally invasive transthoracic surgical ablation of persistent atrial fibrillation. The inclusion and exclusion criteria, definitions, and treatment protocols are those reported by the 2012 Expert Consensus Statement on catheter and surgical ablation of atrial fibrillation. Patients will be randomized to either percutaneous catheter (n = 100) or surgical (n = 50) ablation as the first procedure. After 3 months, they are re-evaluated, according to the same guidelines, and receive a second procedure if necessary. Crossover will be allowed and data analyzed on an "intention-to-treat" basis. Primary outcomes are the incidence of sinus rhythm at 6 and 12 months and the proportions of patients requiring a second procedure.

Discussion: The use of a staged strategy combining surgical and percutaneous approaches might be more favorable in treatment of persistent atrial fibrillation than the controversial single percutaneous ablation.

Trial registration: ISRCTN08035058 Reg 06.20.2013.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of the study.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA 3rd, Page RL, Ezekowitz MD, Slotwiner DJ, Jackman WM, Stevenson WG, Tracy CM. ACCF/AHA TASK FORCE MEMBERS, 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm. 2011;8:157–176. doi: 10.1016/j.hrthm.2010.11.047. - DOI - PubMed
    1. Roten L, Derval N, Jaïs P. Catheter ablation for persistent atrial fibrillation: elimination of triggers is not sufficient. Circ Arrhythm Electrophysiol. 2012;5:1224–1232. doi: 10.1161/CIRCEP.112.974873. Discussion, 1232. - DOI - PubMed
    1. Dixit S, Marchlinski FE, Lin D, Callans DJ, Bala R, Riley MP, Garcia FC, Hutchinson MD, Ratcliffe SJ, Cooper JM, Verdino RJ, Patel VV, Zado ES, Cash NR, Killian T, Tomson TT, Gerstenfeld EP. Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study. Circ Arrhythm Electrophysiol. 2012;5:287–294. doi: 10.1161/CIRCEP.111.966226. - DOI - PubMed
    1. Andrade JG, Macle L, Khairy P, Khaykin Y, Mantovan R, De Martino G, Chen J, Morillo CA, Novak P, Guerra PG, Nair G, Torrecilla EG, Verma A. Incidence and significance of early recurrences associated with different ablation strategies for AF: a STAR-AF substudy. J Cardiovasc Electrophysiol. 2012;23:1295–1301. doi: 10.1111/j.1540-8167.2012.02399.x. - DOI - PubMed
    1. Verma A, Mantovan R, Macle L, De Martino G, Chen J, Morillo CA, Novak P, Calzolari V, Guerra PG, Nair G, Torrecilla EG, Khaykin Y. Substrate and trigger ablation for reduction of atrial fibrillation (STAR AF): a randomized, multicentre, international trial. Eur Heart J. 2010;31:1344–1356. doi: 10.1093/eurheartj/ehq041. - DOI - PMC - PubMed

Publication types

MeSH terms

Associated data